Debt-free Balance SheetA zero-debt balance sheet is a durable structural strength: it reduces insolvency risk, lowers fixed financing costs, and gives management flexibility to fund clinical work or pursue strategic options without immediate debt servicing pressure, improving survivability during commercialization.

Substantial Equity BufferMeaningful shareholders' equity provides a lasting solvency cushion, enabling the company to absorb ongoing operating losses and fund near-term R&D or regulatory milestones without immediate insolvency, which supports runway and lowers short-term default risk.

Cash Burn Has Not AcceleratedStable (non-exploding) cash burn versus prior years is a constructive operational signal: it indicates management has some control over costs and predictable runway needs, making financing plans and milestone-based execution more viable over the medium term.

Bears Say

Effectively Zero RevenuePersistently negligible revenue is a fundamental weakness: it shows the business has not achieved commercial traction or product-market fit, forcing continued reliance on external funding and leaving long-term viability dependent on successful product development and market entry.

Persistent Net LossesOngoing, sizable net losses indicate the company remains pre-profitability with negative operating leverage; absent revenue scaling this trend will deplete equity over time and likely require dilutive capital raises that can constrain shareholder value and strategic autonomy.

Negative Operating And Free Cash FlowRecurring negative operating and free cash flow signals structural funding dependence: until operations generate positive cash, the company must secure financing to sustain R&D and commercialization, increasing execution risk and potential dilution over the medium term.

Neola Medical AB News

Neola Medical’s Pivotal Study: A Game Changer in Neonatal Lung Monitoring?

Neola Medical AB (($SE:NEOLA)) announced an update on their ongoing clinical study. Study Overview: Neola Medical AB is...

4M ago

NEOLA

NEOLA FAQ

What was Neola Medical AB’s price range in the past 12 months?

Neola Medical AB lowest stock price was kr0.60 and its highest was kr3.04 in the past 12 months.

What is Neola Medical AB’s market cap?

Neola Medical AB’s market cap is kr68.28M.

When is Neola Medical AB’s upcoming earnings report date?

Neola Medical AB’s upcoming earnings report date is May 27, 2026 which is in 90 days.

How were Neola Medical AB’s earnings last quarter?

Neola Medical AB released its earnings results on Feb 12, 2026. The company reported -kr0.034 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.034.

Is Neola Medical AB overvalued?

According to Wall Street analysts Neola Medical AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Neola Medical AB pay dividends?

Neola Medical AB does not currently pay dividends.

What is Neola Medical AB’s EPS estimate?

Neola Medical AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Neola Medical AB have?

Neola Medical AB has 77,950,230 shares outstanding.

What happened to Neola Medical AB’s price movement after its last earnings report?

Neola Medical AB reported an EPS of -kr0.034 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.267%.

Which hedge fund is a major shareholder of Neola Medical AB?

Currently, no hedge funds are holding shares in SE:NEOLA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Neola Medical AB

Neola Medical AB (publ) develops medical equipment for continuous monitoring of the lungs of premature babies. It offers neonatal intensive care with NEOLA, a medical device that offer continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. NEOLA provides intensive care and healthier lives for preterm born infants. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was incorporated in 2016 and is headquartered in Lund, Sweden.